期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

血管紧张素转换酶抑制剂与脑卒中防治 被引量：2

Effects of ACEI in Stroke Treatment and Prevention
下载PDF
导出
摘要 血管紧张素转换酶抑制剂(ACEI)是重要的抗高血压药物之一,很多证据表明,ACEI除具有降血压作用外,对心脑血管还具有重要的保护作用,可以预防中风发生。本文通过检索MEDLINE数据库和Cochrane图书馆光盘数据库的随机对照试验和系统评价,评价ACEI类药物预防脑卒中的机制和在脑卒中防治中的作用,为临床实践提供循证医学的最佳证据。 Angiotensin converting enzyme inhibitor (ACEI) is an important type of antihypertensive drug. Much evidence shows that ACEI not only decreases the blood pressure but also has the protective effect on the cardiac and cerebral vessels. ACEI may prevent the stroke. To provide the best evidence for the clinical practice, we electronically searched RCTs and systematic reviews from MEDLINE and The Cochrane Library to evaluate the mechanisms and the effects of ACEI in stroke treatment and prevention.
作者 何俐 吴波 杨蓉
机构地区 四川大学华西医院神经内科
出处 《中国循证医学杂志》 CSCD 2005年第1期62-66,共5页 Chinese Journal of Evidence-based Medicine
关键词 血管紧张素转换酶抑制剂 脑卒中 循证医学 Angiotensin converting enzyme inhibitors Stroke Evidence-based medicine
分类号 R743.3 [医药卫生—神经病学与精神病学]
  • 相关文献

参考文献23

  • 1Song YM, Sung J, Lawlor DA, Smith DG, Shin Y, Ebrahim S.Blood pressure, haemorrhagic stroke, and ischaemic stroke: the Korean national prospective occupational cohort study [ J ]. BM J, 2004;328(12): 324 -325
  • 2He J, Whelton PK. Elevated systolic blood pressure and risk of cardiovascular and renal disease: overview of evidence from observational epidemiologic studies and randomized controlled trials [J ]. Am HeartJ , 1999; 138 (3 Pt2): 211 -219
  • 3Hansson L, Zanchetti A, Carruthers SG, Dahlof B, Elmfeldt D, Julius S, MenardJ, Rahn KH, Wedel H, Westerling S. Effect of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the hypertension optimal treatment (HOT) ransomised trial[J]. Lancet, 1998; 351(21): 1 755-1762
  • 4顾东风,Jiang He,吴锡桂,Kristi Reynolds,甘文奇,刘东海,宿少勇,段秀芳,黄广勇,Paul K.Whelton.中国成年人高血压患病率、知晓率、治疗和控制状况[J].中华预防医学杂志,2003,37(2):84-89. 被引量：554
  • 5O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL,Wolfson SK, and The Cardiovascular Health Study Collaborative Research Group. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults[J]. N Engl J Med, 1999; 340(246): 14-22
  • 6Haskell W, Berra K, Clark A, Christopherson D, Duff S,George J, Klieman L, Myll J. Late-Breaking Clinical Trial Abstracts [J]. Circulation, 2003; 108(32): 2 723
  • 7Williams B, Poulter NR, Brown MJ, Davis M, McInnes GT, Potter JF, Sever PS, Thom SM; BHS guidelines working party, for the British Hypertension Society. British hypertension society guidelines for hypertension management 2004 (BFS-Ⅳ): summary [ J ]. BMJ,2004; 328(2 351 ): 634 -640
  • 8Turnbull F and Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials[J]. Lancet, 2003; 362(2 368): 1 527 - 1 535
  • 9Brookes L. The plaque hypertension lipid-lowering Italian study (PHYLLIS) [ A ]. 1 st Joint Meeting of the International and European Societies of Hypertension, Jul 2002
  • 10Migdalis IN, Gerolimous B, Kozanidou G, Hatzigakis SM, Karmaniolas KD. Effect of fosinopril sodium on early carotid atherosclerosis in diabetic patients with hypertension [ J ]. Journal of Medicine, 1997;28(6): 371 -380

二级参考文献13

  • 1全国血压抽样调查协作组.中国人群高血压患病率及其变化趋势[J].高血压杂志,1995,3(A01):7-13. 被引量：508
  • 2Lopez AD. Assessing the burden of mortality from cardiovascular diseases. World Health Stat Q,1993,46:91-96.
  • 3Murray CJ,Lopez AD. Global pattern of cause of death and burden of disease in 1990,with projections to 2020 investing in health research and development report of the ad hoc committee on health research relation to future intervention options. Geneva WHO,1996.
  • 4Wu Z,Yao C,Zhao D,et al. Sino-MONICA project: a collaborative study on trends and determinants in cardiovascular diseases in China,Part I: morbidity and mortality monitoring. Circulation,2001,103:462-468.
  • 5Rodgers A,MacMahon S. Blood pressure and the global burden of cardiovascular disease. Clin Exp Hypertens,1999,21:543-552.
  • 6Klag MJ,Whelton PK,Randall BL,et al. Blood pressure and end-stage renal disease in men. N Engl J Med,1996,334:13-18.
  • 7Eastern Stroke and Coronary Heart Disease Collaborative Research Group. Blood pressure,cholesterol,and stroke in eastern Asia. Lancet,1998,352:1801-1807.
  • 8Tatsanavivat P,Klungboonkrong V,Chirawatkul A,et al. Prevalence of coronary heart disease and major cardiovascular risk factors in Thailand. Int J Epidemiol,1998,27:405-409.
  • 9Wolz M,Cutler J,Roccella EJ,et al. Statement from the National High Blood Pressure Education Program: prevalence of hypertension. Am J Hypertens,2000,13:103-104.
  • 10Primatesta P,Brookes M,Poulter NR. Improved hypertension management and control: results from the health survey for England 1998. Hypertension,2001,38: 827-832.

共引文献553

同被引文献39

引证文献2

二级引证文献27

中国循证医学杂志
2005年 第1期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部